Biological Scaffolds for Congenital Heart Disease
Congenital heart disease (CHD) is the most predominant birth defect and can require several invasive surgeries throughout childhood. The absence of materials with growth and remodelling potential is a limitation of currently used prosthetics in cardiovascular surgery, as well as their susceptibility...
Main Authors: | Amy G. Harris, Tasneem Salih, Mohamed T. Ghorbel, Massimo Caputo, Giovanni Biglino, Michele Carrabba |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/10/1/57 |
Similar Items
-
Recent Advances in Hydrogel-Based 3D Bioprinting and Its Potential Application in the Treatment of Congenital Heart Disease
by: Tasneem Salih, et al.
Published: (2024-07-01) -
Stem cell therapy and tissue engineering for correction of congenital heart disease
by: Elisa eAvolio, et al.
Published: (2015-06-01) -
In Vitro and In Vivo Preclinical Testing of Pericyte‐Engineered Grafts for the Correction of Congenital Heart Defects
by: Valeria Vincenza Alvino, et al.
Published: (2020-02-01) -
Recent advances and challenges on application of tissue engineering for treatment of congenital heart disease
by: Antonia Mantakaki, et al.
Published: (2018-10-01) -
Educational attainment in patients with congenital heart disease: a comprehensive systematic review and meta-analysis
by: Lucia Cocomello, et al.
Published: (2021-11-01)